Ballicules.com

Mirtazapine and Dexmedetomidine: an Alpha-2 adrenergic receptor interaction

Mirtazapine blocks the alpha-2 adrenergic receptor, so Dexmedetomidine cannot act there — the effect of Dexmedetomidine is reduced or lost.

Dexmedetomidine is an agonist at the alpha-2 adrenergic receptor: it binds and switches the receptor on. Mirtazapine is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Dexmedetomidine’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Mirtazapine versus Dexmedetomidine over the Alpha-2 adrenergic receptor
Fight club: Mirtazapine versus Dexmedetomidine — Alpha-2 adrenergic receptor

The two ballicules, with the Alpha-2 adrenergic receptor lit on each

Mirtazapine ballicule, with its Alpha-2 adrenergic receptor peg ringed
Mirtazapine (REMERON)
Alpha-2 adrenergic receptor antagonist
Dexmedetomidine ballicule, with its Alpha-2 adrenergic receptor peg ringed
Dexmedetomidine (PRECEDEX)
Alpha-2 adrenergic receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Mirtazapine mascot mnemonic cartoon
Mirtazapine
“(Remember) Mr Taz zapping”
Dexmedetomidine mascot mnemonic cartoon
Dexmedetomidine
“Pre-sedate (for) Death metal toe meeting”

Open it in the console